Richiede l'autenticazione

Transfusions for patients with sickle cell disease at Children’s Hospital Boston

   | 01 dic 2019
INFORMAZIONI SU QUESTO ARTICOLO

Cita

Adams RJ, Brambilla D; Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769–78.10.1056/NEJMoa05046016382063Search in Google Scholar

Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5–11.10.1056/NEJM1998070233901029647873Search in Google Scholar

Adams DM, Schultz WH, Ware RE, Kinney TR. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol 1996;18:46–50.10.1097/00043426-199602000-000098556370Search in Google Scholar

eISSN:
1930-3955
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, Laboratory Medicine